Revelation Biosciences Inc (REVB)

$2.38 -0.32 (-11.71%)
Market Cap 4.42M
Revenue (ttm) 0.00
Net Income (ttm) -15.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 404,319
Avg Vol 526,363
Day's Range N/A - N/A
Shares Out 1.53M
Stochastic %K 2%
Beta -0.08
Analysts Strong Sell
Price Target $21.45

Company Profile

Revelation Biosciences, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed...

Industry: Biotechnology
Sector: Healthcare
Phone: (650) 800-3717
Address:
4660 La Jolla Village Drive, Suite 100, San Diego, United States
SkyLonger
SkyLonger Jul. 29 at 5:07 PM
$REVB panic will be a nothing burger.. $4-10 soon enough 🤙
0 · Reply
OrangeJoolius
OrangeJoolius Jul. 29 at 4:29 PM
$REVB Massive selling, biggest red candle today in over a month. Someone knows the data is bed. REVB is another JAGX.
1 · Reply
thaboss8854
thaboss8854 Jul. 29 at 4:19 PM
$REVB the entire market is down due, and now rumors about a leak and the data being bad. Well they are delayed with the data for sure but I am holding it.
1 · Reply
OrangeJoolius
OrangeJoolius Jul. 29 at 3:36 PM
$REVB Removed from watchlist. The data is bad, clearly a leak
1 · Reply
OrangeJoolius
OrangeJoolius Jul. 29 at 1:21 PM
$REVB Out temporarily until panic selling and stop loss hunting stops. Will buy back in of it rises today, but otherwise holding now doesn't make sense if everyone is selling. I have 20k now to buy back in lower. Still 100% bullish here.
0 · Reply
_highrider_
_highrider_ Jul. 29 at 9:10 AM
$REVB see you @ 10$
1 · Reply
thaboss8854
thaboss8854 Jul. 28 at 9:29 PM
$REVB we have been getting Short attack eh hahaha. Too bad I am just patiently holding waiting for the shorts to get burned
0 · Reply
OrangeJoolius
OrangeJoolius Jul. 28 at 7:50 PM
$REVB I'm happy to follow it all the way down to the 52 week low again if they want to take it there. I have another 10k earmarked to average down if need be. You guys wanna sell, then sell. 🙏
0 · Reply
Luvtoretire
Luvtoretire Jul. 28 at 7:40 PM
$REVB —It’s so much fun watching all the other low float nothing stocks fly on the PR the CEO’s kid getting into college.
1 · Reply
m_tokac52
m_tokac52 Jul. 28 at 7:29 PM
$VAPE $REVB is low float and clinical data on August 8 is worth looking at.
0 · Reply
Latest News on REVB
Revelation Biosciences, Inc. Congratulates Its Former Chairman of the Board, George Tidmarsh, on His Appointment as the Head of the FDA Center for Drug Evaluation and Research

Jul 24, 2025, 9:00 AM EDT - 5 days ago

Revelation Biosciences, Inc. Congratulates Its Former Chairman of the Board, George Tidmarsh, on His Appointment as the Head of the FDA Center for Drug Evaluation and Research

Revelation Biosciences Inc. Completes Dosing of Patients in PRIME Study

Jul 16, 2025, 9:00 AM EDT - 13 days ago

Revelation Biosciences Inc. Completes Dosing of Patients in PRIME Study

Revelation Biosciences Inc. Announces 1-for-3 Reverse Stock Split Effective July 7, 2025

Jul 1, 2025, 5:26 PM EDT - 4 weeks ago

Revelation Biosciences Inc. Announces 1-for-3 Reverse Stock Split Effective July 7, 2025

Revelation Biosciences, Inc. Announces Closing of $4 Million Public Offering

May 29, 2025, 4:05 PM EDT - 2 months ago

Revelation Biosciences, Inc. Announces Closing of $4 Million Public Offering

Revelation Biosciences, Inc. Announces Pricing of $4 Million Public Offering

May 29, 2025, 8:00 AM EDT - 2 months ago

Revelation Biosciences, Inc. Announces Pricing of $4 Million Public Offering

Revelation Biosciences Announces Retirement of George Tidmarsh, MD, PhD from Board of Directors

May 23, 2025, 4:05 PM EDT - 2 months ago

Revelation Biosciences Announces Retirement of George Tidmarsh, MD, PhD from Board of Directors

Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2025

May 8, 2025, 4:15 PM EDT - 2 months ago

Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2025

Revelation Biosciences to Develop Gemini for Infection in Severe Burn Patients

Apr 29, 2025, 9:00 AM EDT - 3 months ago

Revelation Biosciences to Develop Gemini for Infection in Severe Burn Patients

Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells

Mar 17, 2025, 6:00 AM EDT - 4 months ago

Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells

Revelation Biosciences to Host Fireside Chat at 37th Annual Roth Conference

Mar 13, 2025, 6:00 AM EDT - 4 months ago

Revelation Biosciences to Host Fireside Chat at 37th Annual Roth Conference

Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2024

Mar 6, 2025, 4:15 PM EST - 5 months ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2024

Revelation Biosciences Doses First Patient in PRIME Phase 1b Clinical Study of Gemini in CKD Patients

Feb 26, 2025, 6:00 AM EST - 5 months ago

Revelation Biosciences Doses First Patient in PRIME Phase 1b Clinical Study of Gemini in CKD Patients

Revelation Biosciences, Inc. Receives Continued NASDAQ Listing Approval

Feb 24, 2025, 6:00 AM EST - 5 months ago

Revelation Biosciences, Inc. Receives Continued NASDAQ Listing Approval

Revelation Biosciences Inc. Announces 1-for-16 Reverse Stock Split Effective January 28, 2025

Jan 24, 2025, 6:00 AM EST - 6 months ago

Revelation Biosciences Inc. Announces 1-for-16 Reverse Stock Split Effective January 28, 2025

Revelation Biosciences Starts its PRIME Phase 1b Clinical Study of Gemini in CKD Patients

Jan 21, 2025, 6:00 AM EST - 6 months ago

Revelation Biosciences Starts its PRIME Phase 1b Clinical Study of Gemini in CKD Patients

Revelation Biosciences Inc. Reminds You to Vote for the Special Meeting on January 17, 2025

Jan 13, 2025, 6:00 AM EST - 7 months ago

Revelation Biosciences Inc. Reminds You to Vote for the Special Meeting on January 17, 2025

Nasdaq Grants Revelation Biosciences Inc. Continued Listing

Jan 6, 2025, 6:00 AM EST - 7 months ago

Nasdaq Grants Revelation Biosciences Inc. Continued Listing

Revelation Biosciences Inc. Announces Exercise of Warrants for $4 Million in Gross Proceeds

Dec 3, 2024, 8:38 AM EST - 8 months ago

Revelation Biosciences Inc. Announces Exercise of Warrants for $4 Million in Gross Proceeds

Revelation Biosciences Inc. Announces FDA Acceptance of Gemini IND

Dec 2, 2024, 6:00 AM EST - 8 months ago

Revelation Biosciences Inc. Announces FDA Acceptance of Gemini IND

Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply

Nov 12, 2024, 6:00 AM EST - 9 months ago

Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024

Nov 8, 2024, 4:15 PM EST - 9 months ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024

Revelation Biosciences' Gemini Induces Dose Dependent Significant Increases in IL-10

Sep 24, 2024, 6:00 AM EDT - 11 months ago

Revelation Biosciences' Gemini Induces Dose Dependent Significant Increases in IL-10

Revelation Biosciences Inc. Announces Exercise of Warrants for $3.8 Million in Gross Proceeds

Aug 21, 2024, 5:30 PM EDT - 1 year ago

Revelation Biosciences Inc. Announces Exercise of Warrants for $3.8 Million in Gross Proceeds

Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2024

Aug 9, 2024, 4:15 PM EDT - 1 year ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2024

Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity

Jun 24, 2024, 9:00 AM EDT - 1 year ago

Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity

Revelation Biosciences Has Completed Dosing of its First in Human Phase 1 Clinical Study of Gemini

Jun 13, 2024, 9:21 AM EDT - 1 year ago

Revelation Biosciences Has Completed Dosing of its First in Human Phase 1 Clinical Study of Gemini

Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024

May 10, 2024, 4:52 PM EDT - 1 year ago

Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024

Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023

Mar 22, 2024, 4:15 PM EDT - 1 year ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023

Revelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024)

Mar 13, 2024, 9:00 AM EDT - 1 year ago

Revelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024)

Revelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth Conference

Mar 12, 2024, 9:00 AM EDT - 1 year ago

Revelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth Conference

Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini

Mar 4, 2024, 9:00 AM EST - 1 year ago

Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini

Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)

Feb 13, 2024, 9:00 AM EST - 1 year ago

Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)

Top 5 Health Care Stocks That Are Preparing To Pump In February

Feb 9, 2024, 8:35 AM EST - 1 year ago

Top 5 Health Care Stocks That Are Preparing To Pump In February

CNSP GILD ZLAB

Revelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering

Feb 5, 2024, 4:41 PM EST - 1 year ago

Revelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering

Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering

Feb 1, 2024, 6:00 AM EST - 1 year ago

Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering

Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)

Jan 30, 2024, 9:00 AM EST - 1 year ago

Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)

Revelation Biosciences Inc. Announces 1-for-30 Reverse Stock Split Effective January 25, 2024

Jan 23, 2024, 9:00 AM EST - 1 year ago

Revelation Biosciences Inc. Announces 1-for-30 Reverse Stock Split Effective January 25, 2024

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2023

Nov 13, 2023, 4:05 PM EST - 1 year ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2023

Gemini Induces Pharmacologic Activity and Related Physiologic Changes in Multiple Preclinical Studies

Oct 12, 2023, 9:00 AM EDT - 1 year ago

Gemini Induces Pharmacologic Activity and Related Physiologic Changes in Multiple Preclinical Studies

Revelation Biosciences, Inc. to Present at the 2023 ROTH Healthcare Opportunities Conference

Oct 4, 2023, 9:00 AM EDT - 1 year ago

Revelation Biosciences, Inc. to Present at the 2023 ROTH Healthcare Opportunities Conference

Revelation Biosciences Inc. Announces Appointment of Lakhmir Chawla, M.D. to Board of Directors

Oct 2, 2023, 9:00 AM EDT - 1 year ago

Revelation Biosciences Inc. Announces Appointment of Lakhmir Chawla, M.D. to Board of Directors

Revelation Biosciences Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2023

Aug 11, 2023, 4:10 PM EDT - 2 years ago

Revelation Biosciences Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2023

REMINDER: Revelation Biosciences, Inc. Urges All Stockholders to Vote at the 2023 Annual Meeting of Stockholders

Jun 29, 2023, 9:00 AM EDT - 2 years ago

REMINDER: Revelation Biosciences, Inc. Urges All Stockholders to Vote at the 2023 Annual Meeting of Stockholders

Revelation Biosciences Inc. Announces Adjournment of 2023 Annual Meeting of Stockholders to July 7, 2023 and Additional Proposal

Jun 12, 2023, 4:15 PM EDT - 2 years ago

Revelation Biosciences Inc. Announces Adjournment of 2023 Annual Meeting of Stockholders to July 7, 2023 and Additional Proposal

Revelation Biosciences Inc. Announces Financial Results for the Three Months Ended March 31, 2023 and Recent Corporate Progress

May 22, 2023, 9:00 AM EDT - 2 years ago

Revelation Biosciences Inc. Announces Financial Results for the Three Months Ended March 31, 2023 and Recent Corporate Progress

Revelation Biosciences Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2022 and Recent Corporate Progress

Mar 30, 2023, 5:42 PM EDT - 2 years ago

Revelation Biosciences Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2022 and Recent Corporate Progress

Revelation Biosciences Inc. Appoints Dr. Julia Bohannon and Dr. Antonio Hernandez to Scientific Advisory Board

Mar 13, 2023, 9:00 AM EDT - 2 years ago

Revelation Biosciences Inc. Appoints Dr. Julia Bohannon and Dr. Antonio Hernandez to Scientific Advisory Board

Revelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth Conference

Mar 6, 2023, 9:00 AM EST - 2 years ago

Revelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth Conference

Revelation Biosciences Inc. Announces Closing of $15.6 Million Public Offering

Feb 13, 2023, 4:20 PM EST - 2 years ago

Revelation Biosciences Inc. Announces Closing of $15.6 Million Public Offering

Revelation Biosciences Inc. Announces Pricing of $15.6 Million Public Offering

Feb 9, 2023, 9:42 AM EST - 2 years ago

Revelation Biosciences Inc. Announces Pricing of $15.6 Million Public Offering

SkyLonger
SkyLonger Jul. 29 at 5:07 PM
$REVB panic will be a nothing burger.. $4-10 soon enough 🤙
0 · Reply
OrangeJoolius
OrangeJoolius Jul. 29 at 4:29 PM
$REVB Massive selling, biggest red candle today in over a month. Someone knows the data is bed. REVB is another JAGX.
1 · Reply
thaboss8854
thaboss8854 Jul. 29 at 4:19 PM
$REVB the entire market is down due, and now rumors about a leak and the data being bad. Well they are delayed with the data for sure but I am holding it.
1 · Reply
OrangeJoolius
OrangeJoolius Jul. 29 at 3:36 PM
$REVB Removed from watchlist. The data is bad, clearly a leak
1 · Reply
OrangeJoolius
OrangeJoolius Jul. 29 at 1:21 PM
$REVB Out temporarily until panic selling and stop loss hunting stops. Will buy back in of it rises today, but otherwise holding now doesn't make sense if everyone is selling. I have 20k now to buy back in lower. Still 100% bullish here.
0 · Reply
_highrider_
_highrider_ Jul. 29 at 9:10 AM
$REVB see you @ 10$
1 · Reply
thaboss8854
thaboss8854 Jul. 28 at 9:29 PM
$REVB we have been getting Short attack eh hahaha. Too bad I am just patiently holding waiting for the shorts to get burned
0 · Reply
OrangeJoolius
OrangeJoolius Jul. 28 at 7:50 PM
$REVB I'm happy to follow it all the way down to the 52 week low again if they want to take it there. I have another 10k earmarked to average down if need be. You guys wanna sell, then sell. 🙏
0 · Reply
Luvtoretire
Luvtoretire Jul. 28 at 7:40 PM
$REVB —It’s so much fun watching all the other low float nothing stocks fly on the PR the CEO’s kid getting into college.
1 · Reply
m_tokac52
m_tokac52 Jul. 28 at 7:29 PM
$VAPE $REVB is low float and clinical data on August 8 is worth looking at.
0 · Reply
RainManCash
RainManCash Jul. 28 at 6:37 PM
$REVB added again
0 · Reply
hassan101
hassan101 Jul. 28 at 5:15 PM
$REVB U
0 · Reply
OrangeJoolius
OrangeJoolius Jul. 28 at 4:21 PM
$REVB There is the expected stop loss raid. Bought the dip.
0 · Reply
D2theK
D2theK Jul. 28 at 3:03 PM
$REVB Don’t be sorry for not buying the warrants, be sorry for buying them $REVBW
0 · Reply
Rjhall0521
Rjhall0521 Jul. 26 at 2:37 AM
$REVB the main catalyst in phase 1 most will be looking for is how it does halting CKD so let’s hope those biomarkers are good!
0 · Reply
OrangeJoolius
OrangeJoolius Jul. 25 at 7:25 PM
$REVB You can feel how low the float is, small buys send it up 8-10 cents. When positive data drops this likely runs over $4-5 easy.
0 · Reply
OhNoTheSkyIsFalling
OhNoTheSkyIsFalling Jul. 25 at 6:33 PM
$REVB Don't be shy guys. Friday is almost over. Sell me your shares at 2.80 or below.
0 · Reply
Pipelinepivots
Pipelinepivots Jul. 25 at 5:42 PM
TGL The best setups don’t shout they whisper. And this one’s whispering: “AI. Blockchain. Users. Q3 Launch. Under $2.” You either listen early, or chase late. I’ve already moved. $REVB $QH $IMUX $MN
0 · Reply
OrangeJoolius
OrangeJoolius Jul. 25 at 3:57 PM
$REVB Back in, but they need to get a move on with releasing this data.
0 · Reply
DM0n3y
DM0n3y Jul. 25 at 2:53 PM
$REVB low floater. news will have this up nicely
0 · Reply
Chronlogic
Chronlogic Jul. 25 at 2:27 PM
$REVB just needs some volume
0 · Reply
Rjhall0521
Rjhall0521 Jul. 25 at 1:21 PM
$REVB still being patient with this one. Any day now!
0 · Reply